Citadel Advisors’s Scansource SCSC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,100
Closed -$71.4K 14769
2025
Q1
$71.4K Buy
2,100
+1,200
+133% +$48.9K ﹤0.01% 11887
2024
Q4
$42.7K Sell
900
-1,900
-68% -$92.9K ﹤0.01% 12553
2024
Q3
$134K Buy
2,800
+2,100
+300% +$99.4K ﹤0.01% 10699
2024
Q2
$31K Buy
+700
New +$31.3K ﹤0.01% 12233
2023
Q4
Sell
-3,500
Closed -$106K 15128
2023
Q3
$106K Buy
3,500
+500
+17% +$15K ﹤0.01% 10829
2023
Q2
$88.7K Sell
3,000
-1,400
-32% -$40.5K ﹤0.01% 11106
2023
Q1
$134K Buy
4,400
+600
+16% +$18.6K ﹤0.01% 10826
2022
Q4
$111K Buy
+3,800
New +$113K ﹤0.01% 11069
2021
Q4
Sell
-6,900
Closed -$240K 14652
2021
Q3
$240K Buy
+6,900
New +$212K ﹤0.01% 11572
2021
Q2
Sell
-8,200
Closed -$246K 14332
2021
Q1
$246K Buy
+8,200
New +$238K ﹤0.01% 11272

Other funds holding SCSC

Citadel Advisors's SCSC Position: Q1 2026 in Review

Citadel Advisors increased its Scansource (SCSC) stake by 100% in Q1 2026, buying an estimated $2.51M and bringing the position to 131,621 shares worth $4.78M. The position accounts for ﹤0.01% of the portfolio, ranked #4415.

Citadel Advisors first reported a position in SCSC in Q2 2013 and has held it in 43 quarters since. The position peaked at $17.6M in Q2 2025. 202 funds tracked by Wall St. Rank hold SCSC as of Q1 2026.

  • Citadel Advisors held 131,621 shares of Scansource worth $4.78M as of Q1 2026.
  • Citadel Advisors bought 65,729 Scansource shares in Q1 2026, an estimated $2.51M.
  • Scansource made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #4415 holding.
  • Citadel Advisors first reported a position in Scansource in Q2 2013 and has held it in 43 quarters since.
  • Citadel Advisors's Scansource position peaked at $17.6M in Q2 2025.
  • 202 funds tracked by Wall St. Rank held Scansource as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.